Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FQAJU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,698
Award facts
- Contract value 100% obligated
- $13,697.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,697.84 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, awarded on September 18, 2025, with an ultimate completion date of October 9, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract carries no set-aside designation, allowing the vendor to compete on its merits within the open market while leveraging its woman-owned small business status.
This delivery order is issued under DMS Pharmaceutical Group's $500 million single-award Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, which remains valid through November 2026. The vendor serves as a critical supplier within the federal pharmaceutical supply chain, distributing prescription medications, biologics, and medical consumables to Department of Defense healthcare facilities worldwide. Xolair, a biologic medication for severe allergic asthma, represents the type of specialty pharmaceutical products the company routinely supplies to military health facilities under this comprehensive procurement vehicle.
Quick answers
Who was awarded contract SPE2DB25FQAJU?
SPE2DB25FQAJU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FQAJU worth?
The government has obligated $13,698 on SPE2DB25FQAJU.
Is contract SPE2DB25FQAJU an order under another contract?
Yes. SPE2DB25FQAJU is a delivery order under SPE2DB25D9305, an indefinite delivery contract.
Was contract SPE2DB25FQAJU competed?
The extent of competition for SPE2DB25FQAJU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award